More Arovella Therapeutics Limited news
Arovella Therapeutics LimitedASX: ALA

Financial Update and Refund Of Rights Issue

Mar 30, 2016 at 5:36 AM EDT · Issued by Arovella Therapeutics Limited

Filed with ASX · Mar 30, 2016 at 5:36 AM EDT

On 6ix: 6ix.com/news/financial-update-and-refund-of-rights-issue

View Attachment

6ix hasn’t read this filing yet.

Arovella Therapeutics Limited on 6ix

Earlier from Arovella Therapeutics

  • UPDATEMar 30, 2016
  • Positive trial resultsMar 30, 2016
  • ArTiMist - CLINICAL TRIAL STATUS REPORTMar 30, 2016
  • Westcoast Surgical and Medical SuppliesMar 30, 2016
  • Update on Eastland`s subsidiaryMar 30, 2016

Later from Arovella Therapeutics

  • Eastland ArTiMist UpdateMar 30, 2016
  • Successful completion of phase 1 multi-dose studyMar 30, 2016
  • Anti-Malaria Treatment ArTiMist Enters ProductionMar 30, 2016
  • ArTiMist trial updateMar 30, 2016
  • Commitments Test Entity - Third Quarter ReportMar 30, 2016
All Arovella Therapeutics news releases↗

Follow Arovella Therapeutics into a list and get an email when it puts out news.

Follow Arovella Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer